Search results
Emergent BioSolutions to close Baltimore, Rockville plants, lay off 300 workers
Baltimore Sun· 2 hours agoEmergent BioSolutions — maker of the overdose reversal drug Narcan — plans to shutter its...
COVID-19 Vaccine Uptake in Undocumented Latinx Patients
Journal of the American Medical Association· 6 days agoThis cross-sectional study examines COVID-19 infection status, vaccination uptake, and perceptions about the vaccine among Latinx patients presenting to the emergency department in California.
CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine
Benzinga· 6 days agoHONG KONG, Apr 26, 2024 - (ACN Newswire) - On April 20, the 2024 National Vaccines and Health Conference organized by the Chinese Preventive Medicine Association (CPMA) and ...
Peloton Cutting About 400 Jobs Worldwide; CEO Stepping Down
Time Magazine· 1 hour agoPeloton is cutting about 400 jobs worldwide as part of a restructuring effort and its CEO Barry...
EXPLAINER: Boosters key to fight omicron, lot still to learn
AOL· 8 hours agoThe new omicron variant took only a few weeks to live up to dire predictions about how hugely...
What is at stake in UK local voting ahead of a looming general election
The Hill· 2 hours agoMillions of voters in England and Wales will cast their ballots on Thursday in an array of local...
Maine high court says EMS Board had authority to impose vaccine mandate
Bangor Daily News· 6 days agoMaine’s highest court has ruled a state board overseeing emergency medical service workers had the...
What is at stake in UK local voting ahead of a looming general election
San Francisco Chronicle· 2 hours agoMillions of voters in England and Wales will cast their ballots on Thursday in an array of local...
Peloton cutting about 400 jobs worldwide; CEO McCarthy stepping down
WFTV 9 Orlando· 3 hours agoMcCarthy is stepping down after two years as the company continues to work on turning around its...
Scientists tried to give people COVID — and failed
Nature· 2 days agoResearchers deliberately infect participants with SARS-CoV-2 in ‘challenge’ trials — but high levels of immunity complicate efforts to test vaccines and...